Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hugo Arasanz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 23

Top Venues

International journal of molecular sciences

Cancers

Journal of personalized medicine

Life (Basel, Switzerland)

Complejo Hospitalario de Navarra

Universidad Pública de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Complejo Hospitalario de Navarra Aug 1o 2018

Spain

Specialist Physician :: Medical Oncology

Education History

Universidad Pública de Navarra Sep 5o 2015 - Feb 24o 2020

Spain

PHD :: Ciencias de la Salud

Publications

Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Ibone Labiano, Ana Elsa Huerta, Virginia Arrazubi, Irene Hernandez-Garcia, Elena Mata, David Gomez, Hugo Arasanz, Ruth Vera, Maria Alsina
State of the Art: ctDNA in Upper Gastrointestinal Malignancies. Cancers 15 (5) (2023)
Ibone Labiano, Ana Elsa Huerta, Virginia Arrazubi, Irene Hernandez-Garcia, Elena Mata, David Gomez, Hugo Arasanz, Ruth Vera, Maria Alsina
State of the Art: ctDNA in Upper Gastrointestinal Malignancies. Cancers 15 (5) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja, Irene Hernandez-Garcia, Hugo Arasanz, Jairo Pérez-Sanz, Ana Isabel Bocanegra, Grazyna Kochan, David Escors, Yerani Ruiz de Azúa, Jesús María Elizalde, Antonio Viúdez, Ruth Vera
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer. Head & neck (2023)
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, Giulia Accardi, Anna Calabrò, Fanny Pojero, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Luisa Chocarro, Miriam Echaide, Leticia Fernandez-Rubio, Pablo Ramos, Sergio Piñeiro-Hermida, Grazyna Kochan, Nahid Zareian, Farzin Farzaneh, David Escors, Calogero Caruso, Giuseppina Candore
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International journal of molecular sciences 23 (17) (2022)
Hugo Arasanz, Ana Isabel Bocanegra, Idoia Morilla, Joaquín Fernández-Irigoyen, Maite Martínez-Aguillo, Lucía Teijeira, Maider Garnica, Ester Blanco, Luisa Chocarro, Karina Ausin, Miren Zuazo, Gonzalo Fernández-Hinojal, Miriam Echaide, Leticia Fernández-Rubio, Sergio Piñeiro-Hermida, Pablo Ramos, Laura Mezquita, David Escors, Ruth Vera, Grazyna Kochan
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer. Cancers 14 (16) (2022)
Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio, Ester Blanco, Miriam Echaide, Ana Isabel Bocanegra, Lucía Teijeira, Maider Garnica, Idoia Morilla, Maite Martínez-Aguillo, Sergio Piñeiro-Hermida, Pablo Ramos, Juan Jose Lasarte, Ruth Vera, Grazyna Kochan, David Escors
CAR-T Cells for the Treatment of Lung Cancer. Life (Basel, Switzerland) 12 (4) (2022)
David Escors, Ana Isabel Bocanegra, Luisa Chocarro, Ester Blanco, Sergio Piñeiro-Hermida, Maider Garnica, Leticia Fernandez-Rubio, Ruth Vera, Hugo Arasanz, Grazyna Kochan
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. International journal of molecular sciences 23 (21) (2022)
Luisa Chocarro, Ana Isabel Bocanegra, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, David Escors, Grazyna Kochan
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor. Cells 11 (15) (2022)
Miriam Echaide, Ibone Labiano, Marina Delgado, Angela Fernández de Lascoiti, Patricia Ochoa, Maider Garnica, Pablo Ramos, Luisa Chocarro, Leticia Fernández, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Sergio Piñeiro-Hermida, Pilar Morente, Ruth Vera, Maria Alsina, David Escors, Grazyna Kochan
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers 14 (18) (2022)
Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti, Giulia Accardi, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Anna Calabrò, Luisa Chocarro, Miriam Echaide, Grazyna Kochan, Leticia Fernandez-Rubio, Pablo Ramos, Fanny Pojero, Nahid Zareian, Sergio Piñeiro-Hermida, Farzin Farzaneh, Giuseppina Candore, Calogero Caruso, David Escors
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. International journal of molecular sciences 23 (17) (2022)
Ester Blanco, Maria Ibañez-Vea, Carlos Hernandez, Lylia Drici, Xabier Martínez de Morentin, Maria Gato, Karina Ausin, Ana Isabel Bocanegra, Miren Zuazo, Luisa Chocarro, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Joaquin Fernandez-Irigoyen, Cristian Smerdou, Maider Garnica, Miriam Echaide, Leticia Fernandez, Pilar Morente, Pablo Ramos-Castellanos, Diana Llopiz, Enrique Santamaria, Martin R Larsen, David Escors, Grazyna Kochan
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets. Journal of personalized medicine 11 (6) (2021)
Luisa Chocarro, Ester Blanco, Miren Zuazo, Hugo Arasanz, Ana Bocanegra, Leticia Fernández-Rubio, Pilar Morente, Gonzalo Fernández-Hinojal, Miriam Echaide, Maider Garnica, Pablo Ramos, Ruth Vera, Grazyna Kochan, David Escors
Understanding LAG-3 Signaling. International journal of molecular sciences 22 (10) (2021)
Hugo Arasanz, Miren Zuazo, Ana Bocanegra, Luisa Chocarro, Ester Blanco, Maite Martínez, Idoia Morilla, Gonzalo Fernández, Lucía Teijeira, Pilar Morente, Miriam Echaide, Natalia Castro, Leticia Fernández, Maider Garnica, Pablo Ramos, David Escors, Grazyna Kochan, Ruth Vera
Hyperprogressive Disease: Main Features and Key Controversies. International journal of molecular sciences 22 (7) (2021)
Carlos Hernandez, Hugo Arasanz, Luisa Chocarro, Ana Isabel Bocanegra, Miren Zuazo, Gonzalo Fernandez-Hinojal, Ester Blanco, Ruth Vera, David Escors, Grazyna Kochan
Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International journal of molecular sciences 21 (7) (2020)
Ana Isabel Bocanegra, Ester Blanco, Gonzalo Fernandez-Hinojal, Hugo Arasanz, Luisa Chocarro, Miren Zuazo, Pilar Morente, Ruth Vera, David Escors, Grazyna Kochan
PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy. International journal of molecular sciences 21 (16) (2020)
Hugo Arasanz, Carlos Hernandez, Ana Isabel Bocanegra, Luisa Chocarro, Miren Zuazo, Maria Gato, Karina Ausin, Enrique Santamaria, Joaquín Fernández-Irigoyen, Gonzalo Fernandez, Eva Santamaría, Carlos Rodríguez, Idoia Blanco-Luquin, Ruth Vera, David Escors, Grazyna Kochan
Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition. Cancers 12 (8) (2020)
Ana Isabel Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, Hugo Arasanz, Maria Jesus Garcia-Granda, Carlos Hernandez, Maria Ibañez, Berta Hernandez-Marin, Maite Martinez-Aguillo, Maria Jose Lecumberri, Angela Fernandez de Lascoiti, Lucia Teijeira, Idoia Morilla, Ruth Vera, David Escors, Grazyna Kochan
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer. International journal of molecular sciences 20 (7) (2019)

Hugo Arasanz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hugo Arasanz